{"id":175730,"date":"2017-05-01T00:00:00","date_gmt":"2017-04-30T22:00:00","guid":{"rendered":"https:\/\/www.bcfi.be\/aripiprazol-en-compulsief-gedrag\/"},"modified":"2026-04-02T19:09:46","modified_gmt":"2026-04-02T17:09:46","slug":"aripiprazol-en-compulsief-gedrag","status":"publish","type":"post","link":"https:\/\/h.cbip.be\/nl\/aripiprazol-en-compulsief-gedrag\/","title":{"rendered":"Aripiprazol en compulsief gedrag"},"content":{"rendered":"<p><strong>Compulsief gedrag<\/strong> (bv. gokverslaving&#x002C; hyperseksualiteit&#x002C; boulimie) is een bekend ongewenst effect van de dopamine-agonisten [zie <a href='https:\/\/www.bcfi.be\/nl\/articles\/1638?folia=1555'>Folia september 2007<\/a>]. De Amerikaanse <em>Food and Drug Administration<\/em> (FDA) publiceerde recent een waarschuwing betreffende het mogelijk optreden van compulsieve gedragsstoornissen met <strong>aripiprazol<\/strong> (Abilify&reg; en generieken)&#x002C; een atypisch antipsychoticum met partieel agonistisch effect op de dopamine-receptoren. Gokverslaving wordt reeds als ongewenst effect vermeld in de SKP van de specialiteiten op basis van aripiprazol. Hoewel compulsief gedrag zelden optreedt bij pati&euml;nten behandeld met aripiprazol&#x002C; moet hieraan gedacht worden bij verergering of optreden van compulsieve gedragsstoornissen.<\/p>\n<p>[<a href='https:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm498662.htm'>www.fda.gov\/Drugs\/DrugSafety\/ucm498662.htm<\/a>]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Compulsief gedrag (bv. gokverslaving&#x002C; hyperseksualiteit&#x002C; boulimie) is een bekend ongewenst  [&#8230;]<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[43,176],"tags":[20213,20224],"class_list":["post-175730","post","type-post","status-publish","format-standard","hentry","category-nieuw","category-2017-nl","tag-import_tags","tag-import_tags-nl"],"_links":{"self":[{"href":"https:\/\/h.cbip.be\/nl\/wp-json\/wp\/v2\/posts\/175730","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/h.cbip.be\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/h.cbip.be\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/h.cbip.be\/nl\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/h.cbip.be\/nl\/wp-json\/wp\/v2\/comments?post=175730"}],"version-history":[{"count":1,"href":"https:\/\/h.cbip.be\/nl\/wp-json\/wp\/v2\/posts\/175730\/revisions"}],"predecessor-version":[{"id":178315,"href":"https:\/\/h.cbip.be\/nl\/wp-json\/wp\/v2\/posts\/175730\/revisions\/178315"}],"wp:attachment":[{"href":"https:\/\/h.cbip.be\/nl\/wp-json\/wp\/v2\/media?parent=175730"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/h.cbip.be\/nl\/wp-json\/wp\/v2\/categories?post=175730"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/h.cbip.be\/nl\/wp-json\/wp\/v2\/tags?post=175730"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}